NUP98 and myelodysplastic syndrome: Patient ALMA_5_PB (0-5 years, male; coverage 11.46x), initially diagnosed with Down Syndrome AML, was predicted as AML with NUP98 fusion/MDS-related secondary myeloid, with trisomy 21 confirmed genomically but no detectable NUP98 fusion.